EQS · EQUASENS · Documents
Market Cap
434.43M EUR
Shares
15.03M
EQUASENS's financial reports and regulated publications, as filed with the market regulator, most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| ESEF Annual Report | 2025-05-07 | 2024-12-31 | |
| ESEF Annual Report | 2023-05-02 | 2022-12-31 | |
| ESEF Annual Report | 2022-05-03 | 2021-12-31 | |
| ESEF Annual Report | 2021-05-18 | 2020-12-31 |
Showing 1–4 of 4 filings
Official financial reports
Official annual, half-year and quarterly publication attachments from DILA / AMF. These are source links, not extracted financial figures. Publication dates are not reporting periods. One publication can have multiple attachments. Source revisions remain separate; do not treat every entry as a current report. Only captured publication months are covered, and gaps may exist. Freshness covers every captured month; CheckedAt is the oldest month check.
| Published (UTC) | Report | Type | Source revision |
|---|---|---|---|
| 2026-09-29 | Rapport Financier Semestriel 2026 Français · 135264_20260929 | Half-year financial and audit report | NEW |
| 2025-11-05 | Equasens: Q3 2025 revenue Anglais · 117183_20251105 | Quarterly financial information | NEW |
| 2025-11-05 | EQUASENS : Chiffre d'affaires au 30 septembre 2025 Français · 137183_20251105 | Quarterly financial information | NEW |
| 2023-11-09 | Equasens: Q3 2023 revenue Anglais · 118610_20231109 | Quarterly financial information | NEW |
| 2023-11-09 | EQUASENS : Chiffre d’affaires du 3ème trimestre 2023 Français · 138610_20231109 | Quarterly financial information | NEW |
| 2023-10-04 | EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023 Français · 132686_20231004 | Half-year financial and audit report | NEW |
| 2020-11-18 | Pharmagest Interactive: 2020 third-quarter revenue: up 25.70% to €44.34m Anglais · 119626_20201118 | Quarterly financial information | NEW |
| 2020-11-18 | PHARMAGEST INTERACTIVE : Forte croissance du chiffre d’affaires du 3ème trimestre 2020 : +25,70% à 44,34 M€ Français · 139626_20201118 | Quarterly financial information | NEW |
| 2019-11-15 | Pharmagest Interactive: Q3 2019 sales Anglais · 113948_20191115 | Quarterly financial information | NEW |
| 2019-11-15 | PHARMAGEST INTERACTIVE : Chiffre d’affaires du T3 2019 Français · 133948_20191115 | Quarterly financial information | NEW |
| 2018-11-14 | PHARMAGEST INTERACTIVE: Q3 2018 revenue: + 19.20 % Anglais · 168808_20181114 | Quarterly financial information | NEW |
| 2018-11-14 | PHARMAGEST INTERACTIVE : Chiffre d'affaires 3ème trimestre 2018 : + 19 Français · 168810_20181114 | Quarterly financial information | NEW |
| 2017-11-17 | PHARMAGEST : CA Q3 2017 : + 8,46% Français · 159402_20171117 | Quarterly financial information | NEW |
| 2017-11-17 | PHARMAGEST : 2017 third-quarter revenue + 8.46 % Anglais · 159401_20171117 | Quarterly financial information | NEW |
| 2017-09-29 | Pharmagest - Rapport Financier semestriel 2017 Français · 158140_20170929 | Half-year financial and audit report | NEW |
| 2016-11-16 | Pharmagest -Third-quarter 2016 turnover Anglais · 149710_20161116 | Quarterly financial information | NEW |
| 2016-11-16 | PHARMAGEST INTERACTIVE : Chiffre d'affaires du 3ème trimestre 2016 Français · 149709_20161116 | Quarterly financial information | NEW |
| 2016-09-30 | Pharmagest - Rapport FInancier Semestriel 2016 Français · 148389_20160930 | Half-year financial and audit report | NEW |
238 publication months captured between 2007-01 and 2026-10; gaps may exist. Oldest month check 2026-09-21 02:08 UTC.
Showing 1–18 of 18 publications